糖尿病性黄斑水肿患者联合应用康柏西普与眼底激光治疗的临床效果分析

目的分析糖尿病性黄斑水肿患者联合应用康柏西普与眼底激光治疗的临床效果,旨意为相关人员的研究工作提供参考文献。方法该试验择取2017年10月—2020年8月该院所收治的96例2型糖尿病性黄斑水肿患者为研究样本。所有受试者均为单眼发病。现依照干预方式不同,将受试者分为对照组48例以及观察组48例。对两组受试者实施眼底激光光凝治疗。以此为基准,观察组受试者联合应用康柏西普治疗疾病,分析结果。结果两组受试者干预前以及干预后1周黄斑中心凹视网膜值差异无统计学意义(P>0.05);相较于对照组,观察组受试者干预后1个月黄斑中心凹视网膜值明显更低,差异有统计学意义(t=3.791,P<0.05);对照组治疗有效率为70.83%,观察组为93.75%,差异有统计学意义(χ²=8.649,P<0.05);干预前,两组受试者BCVA值差异无统计学意义(P>0.05);干预后1周以及干预后1个月,相较于对照组,观察组受试者BCVA值明显更高,差异有统计学意义(t=0.426、3.631、4.390,P<0.05)。结论针对于2型糖尿病性黄斑水肿患者而言,以激光光凝法为基础对患者使用康柏西普治疗疾病,能够取得满意效果。此法有助于全面提升患者最佳矫正视力水平与黄斑中心厚度,安全性强。

Analysis of the Clinical Effect of Combined Application of Conbercept and Fundus Laser Treatment in Patients with Diabetic Macular Edema

Objective To analyze the clinical effects of combined application of Conbercept and fundus laser treatment in patients with diabetic macular edema,in order to provide references for the research work of related personnel.Methods In this trial,96 patients with type 2 diabetic macular edema admitted to the hospital from October 2017 to August 2020 were selected as the study samples.All subjects had monocular disease.According to different intervention methods,the subjects were divided into a control group of 48 cases and an observation group of 48 cases.Two groups of subjects were treated with fundus laser photocoagulation.Using this as a benchmark,the subjects of the observation group were combined with Conbercept for the treatment of diseases,and the results were analyzed.Results There was no statistically significant difference in the macular foveal retina value between the two groups before the intervention and 1 week after the intervention(P>0.05);compared with the control group,the observation group had significantly higher macular foveal retina values?1 month after the intervention,and the difference was statistically significant(t=3.791,P<0.05);the effective rate of treatment in the control group was 70.83%,and that of the observation group was 93.75%,and the difference was statistically significant(χ²=8.649,P<0.05);Before the intervention,there was no statistically significant difference in the BCVA value of the two groups of subjects(P>0.05);1 week after the intervention and 1 month after the intervention,compared with the control group,observe the BCVA value of the group of subjects was significantly higher,and the difference was statistically significant(t=0.426,3.631,4.390,P<0.05).Conclusion For patients with type 2 diabetic macular edema,laser photocoagulation is the basis for patients using Conbercept to treat diseases can achieve satisfactory results.This method helps to comprehensively improve the patient's best corrected visual acuity and the thickness of the center of the macula,with strong safety.